MiR-23a functions as a tumor suppressor in osteosarcoma

Cellular Physiology and Biochemistry

Volumn 34, Issue 5, 2014, Pages 1485-1496

  He, Yu ^a   Meng, Chunqing ^a   Shao, Zengwu ^a   Wang, Hong ^a   Yang, Shuhua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CXCL12; Methylation; MiR 23a; Osteosarcoma; RUNX2

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; MICRORNA 23A; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CELL COUNTING; CELL GROWTH; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; METHYLATION; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; BONE TUMOR; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; NUDE MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

3' UNTRANSLATED REGIONS; ANIMALS; BONE NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84908292868     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366353     Document Type: Article

References (35)

1. Forscher C, Mita M, Figlin R: Targeted therapy for sarcomas. Biologics 2014;8:91-105.
2. Botter SM, Neri D, Fuchs B: Recent advances in osteosarcoma. Curr Opin Pharmacol 2014;16C:15-23.
3. Gill J, Ahluwalia MK, Geller D, Gorlick R: New targets and approaches in osteosarcoma. Pharmacol Ther 2013;137:89-99.
4. Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N; COG Bone Tumor Committee: Children's Oncology Group's 2013 blueprint for research: bone tumors. Pediatr Blood Cancer 2013;60:1009-1015.
5. Bölling T, Hardes J, Dirksen U: Management of bone tumours in paediatric oncology. Clin Oncol (R Coll Radiol) 2013;25:19-26.
6. Szuhai K, Cleton-Jansen AM, Hogendoorn PC, Bovée JV: Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 2012;205:193-204.
7. McManus MT, Sharp PA: Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-747.
8. Eini R, Dorssers LC, Looijenga LH: Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int J Dev Biol 2013;57:319-332.
9. Kuppusamy KT, Sperber H, Ruohola-Baker H: MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr Mol Med 2013;13:757-764.
10. Choi E, Choi E, Hwang KC: MicroRNAs as novel regulators of stem cell fate: World J Stem Cells 2013;5:172-187.
11. Bakhshandeh B, Soleimani M, Paylakhi SH, Ghaemi N: A microRNA signature associated with chondrogenic lineage commitment. J Genet 2012;91:171-182.
12. Shah NR, Chen H: MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014;5:48-60.
13. Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S, Bottoni A, Rosito IA, Liu CG, Burch A, Acunzo M, Pekarsky Y, Alder H, Ciardi A, Croce CM: MicroRNA Profiles Discriminate among Colon Cancer Metastasis. PLoS One 2014;9:e96670.
14. Ishiguro H, Kimura M, Takeyama H: Role of microRNAs in gastric cancer. World J Gastroenterol 2014;20:5694-5699.
15. D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S: The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment. Molecules 2014;19:6393-6406.
16. Kang SM, Lee HJ: MicroRNAs in human lung cancer: Exp Biol Med (Maywood) 2014; pii: 1535370214533887.
17. Nugent M: MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res 2014;6:15-25.
18. Miao J, Wu S, Peng Z, Tania M, Zhang C: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol 2013;34:2093-2098.
19. Zhou G, Shi X, Zhang J, Wu S, Zhao J: MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review. J Int Med Res 2013;41:1-12.
20. Liang W, Gao B, Fu P, Xu S, Qian Y, Fu Q: The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed) 2013;18:788-794.
21. Wang J, Zhang KY, Liu SM, Sen S: Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules 2014;19:1912-1938.
22. Palanichamy JK, Rao DS: miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet 2014;: 54. eCollection 2014.
23. Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM: Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta 2014;1845:255-265.
24. You JS, Jones PA: Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012;22:9-20.
25. Akhavan-Niaki H, Samadani AA: DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys 2013;67:501-513.
26. Jones PA, Liang G: Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009;10:805-811.
27. Subramaniam D, Thombre R, Dhar A, Anant S: DNA Methyltransferases: A Novel Target for Prevention and Therapy. Front Oncol 2014;4:80. eCollection 2014.
28. Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L, Gemma A: MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol 2012;41:869-875.
29. Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N: Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 2014;9:e92921.
30. Bao L, Zhao J, Dai X, Wang Y, Ma R, Su Y, Cui H, Niu J, Bai S, Xiao Z, Yuan H, Yang Z, Li C, Cheng R, Ren X: Correlation between miR-23a and onset of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2014;38:318-330.
31. Hu X, Chen D, Cui Y, Li Z, Huang J: Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. Sci Rep 2013;3:3423.
32. Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, Lobie PE, Zhu T: c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 2013;288:18121-18133.
33. Wang Z, Wei W, Sarkar FH: miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer. Cancer Discov 2012;2:489-491.
34. Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M, Li X: MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 2010;277:3726-3734.
35. Wang WL1, Yang C, Han XL, Wang R, Huang Y, Zi YM, Li JD: MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma. Med Oncol 2014;31:919.